Does Medicaid Cover Ketamine Therapy?

You've been searching for answers. Maybe you found ketamine therapy while researching treatment-resistant depression options, or a friend mentioned it helped them when nothing else did. Now you're wondering if your Medicaid coverage will pay for it.

The short answer: It depends on what type of ketamine treatment you're seeking. Spravato (the FDA-approved nasal spray) has coverage in about 45% of state Medicaid programs. IV ketamine infusions and at-home ketamine therapy have zero Medicaid coverage anywhere in the country.

the country.

Which Situation Are You In?

Find your path below, then skip to the section that applies to you.

What Are the Different Ketamine Treatment Types?

If you're not sure which treatment you're considering, here's a quick comparison.

Spravato (esketamine nasal spray) is the only FDA-approved ketamine formulation for depression. You self-administer the spray in a certified clinic while staff monitor you for two hours. Sessions happen twice weekly initially, then weekly or biweekly. Spravato is the only ketamine type with any Medicaid coverage pathway.

IV ketamine infusions deliver ketamine directly into your bloodstream at a clinic. Sessions last 40–60 minutes with continuous monitoring. The FDA approved ketamine only as an anesthetic in 1970. Using it for depression is off-label, which eliminates Medicaid coverage.

At-home ketamine therapy uses sublingual tablets you take in your own space under telehealth supervision. The at-home format offers the most convenience and lowest cost. No Medicaid coverage exists because its use for depression is off-label.

If You're Seeking Spravato Coverage

You have a realistic shot at coverage, but you'll need to verify your state covers it and navigate prior authorization.

Step 1: Check If Your State Covers Spravato

About 45% of state Medicaid programs cover Spravato. Six states have publicly documented policies:

• Alaska — Covers TRD and MDD with suicidal ideation; requires failed response to 2+ antidepressants
• Alabama — Requires psychiatrist prescriber and 2-hour post-dose monitoring
• Arizona — Accepts multiple billing codes; requires REMS-certified settings
• California — Covered through Medi-Cal since January 2021
• Iowa — New prior authorization requirements effective October 2025
• Texas — Updated criteria effective May 2025

To verify your state: Call the member services number on your Medicaid card and ask: "Does my plan cover Spravato (esketamine nasal spray) for treatment-resistant depression?"

Document the representative's name, ID number, date, and their answer. You may need this later.

Step 2: Meet the Clinical Criteria

Even if your state covers Spravato, you must qualify clinically. 96% of covering programs require prior authorization with documentation showing:

• Diagnosis: Treatment-resistant depression or major depressive disorder with suicidal ideation (DSM-5-TR criteria)
• Treatment history: Inadequate response to at least 2 different antidepressants from different classes, each tried for 8+ weeks at therapeutic doses
• Current severity: Recent PHQ-9, MADRS, or Hamilton Rating Scale scores demonstrating symptom severity

Step 3: Navigate Prior Authorization

The timeline typically runs 2–3 weeks. Starting January 1, 2026, CMS mandates decisions within 7 calendar days.

Your provider will submit documentation. If approved, you'll receive treatment at a REMS-certified facility with mandatory 2-hour monitoring after each dose.

If You're Denied: How to Appeal

You can request a formal "fair hearing" within 60 days of your denial notice. If you want treatment to continue during the appeal, request within 10 days.

For appeals, gather comprehensive records of your antidepressant trials that didn't provide adequate response (medication names, dosages, duration, reasons for inadequate response) plus current severity assessments.

Appeals for Spravato with documented treatment-resistant depression often succeed. The FDA approval gives you leverage.

If Medicaid Won't Cover Your Treatment

If you're seeking IV or at-home ketamine, or your state doesn't cover Spravato, you're paying out-of-pocket. Here's what that looks like and how to make it affordable.

What Treatment Costs Without Coverage

The cost difference is significant. At-home ketamine therapy through Innerwell costs roughly one-sixth what you'd pay for IV infusions at a clinic.

Financial Assistance Options

The Serenity Foundation is the only ketamine-specific charity identified. They sponsor infusion treatment for people who can't afford it. Contact: info@serenityfoundation.org

Hospital charity care applies if you're receiving treatment at a hospital facility. States like New York legally require charity care for people below 300% of the federal poverty level.

HSA/FSA funds can be used for ketamine therapy, effectively saving you 20–30% through tax benefits.

Payment plans through providers like Innerwell let you spread costs over time rather than paying upfront.

Why At-Home Ketamine May Be Your Best Path

If Medicaid won't cover your treatment anyway, the question becomes: how do you access effective care at a price you can manage?

Innerwell delivers at-home ketamine therapy paired with licensed psychotherapist support. This isn't ketamine dropped off with minimal supervision. It's comprehensive mental health care that happens to cost a fraction of clinic-based alternatives.

Innerwell is different in a few key ways:

• Licensed clinicians, not unlicensed guides. Every session is overseen by Master's or Doctoral-level licensed therapists with specialized training through partnerships like Fluence Training.
• Therapeutic support built in. Includes preparation sessions before treatment and integration therapy afterward to help you process insights and translate them into lasting change.
• At-home comfort. Treatment happens in your own space, eliminating travel costs and clinic fees that drive up in-person treatment prices.
• Pricing that reflects the format.
• Foundation Plan: $998 self-pay for 8 treatments ($125 each).
• Extended Plan: $1,999 for 24 treatments ($83 each).

Why the Therapeutic Approach Matters

The medication opens a door. Therapy helps you walk through it.

Ketamine creates a window of neuroplasticity, making your brain more capable of forming new patterns. But that window is most valuable when you use it intentionally with professional guidance. Without therapeutic support, effects don't last as long.

Innerwell members report meaningful results: 69% reduction in depression symptoms, 60% reduction in anxiety symptoms, and 87% see improvement within four weeks. The program maintains a 4.7-star rating.

For those with accepted commercial insurance (Aetna, Cigna/Evernorth, UnitedHealthcare/Optum in certain states), costs start at $54 per treatment.

Take our free assessment to see if at-home ketamine therapy might be right for you.

Frequently Asked Questions

Can I use manufacturer coupons for Spravato if I have Medicaid?

No. The SPRAVATO withMe Savings Program explicitly excludes people with government insurance, including Medicaid and Medicare. If your state covers Spravato, your out-of-pocket cost depends on your plan's cost-sharing structure. Contact member services to confirm.

Why doesn't Medicaid cover IV ketamine for depression?

The FDA approved ketamine only as an anesthetic, not for psychiatric conditions. Using it for depression is off-label. Federal Medicaid law requires coverage of FDA-approved medications, but off-label uses need additional justification. IV ketamine for depression isn't listed in recognized compendia.

What if I have PTSD instead of depression?

Spravato's FDA approval only covers treatment-resistant depression and major depressive disorder with suicidal ideation. Using it for PTSD is off-label, facing the same coverage barriers as IV ketamine. Neither formulation is likely to be covered by Medicaid for PTSD.

Does Innerwell accept Medicaid?

No. Innerwell accepts commercial insurance including Aetna, Cigna/Evernorth, and UnitedHealthcare/Optum in certain states. Without accepted insurance, self-pay options start at $998 for 8 treatments, with payment plans available.